T2DMpoorly-DL-P versus H |
Cell Cycle, Cell-To-Cell Signaling and Interaction, Hematological System Development and Function |
33 |
Cellular Movement, Immune Cell Trafficking, Connective Tissue Disorders |
31 |
Antimicrobial Response, Inflammatory Response, Dermatological Diseases and Conditions |
31 |
Cellular Movement, Cellular Development, Cellular Growth and Proliferation |
31 |
Cellular Movement, Cancer, Organismal Injury and Abnormalities |
29 |
T2DMwell-DL-P versus H |
Cellular Movement, Immune Cell Trafficking, Cell-mediated Immune Response |
37 |
Infectious Diseases, Immunological Disease, Connective Tissue Disorders |
33 |
Hematological System Development and Function, Tissue Morphology, Cell-To-Cell Signaling and Interaction |
33 |
Cardiovascular System Development and Function, Tissue Morphology, Digestive System Development and Function |
29 |
Cell Death and Survival, Inflammatory Response, Organismal Injury and Abnormalities |
27 |
DL-P versus H |
Cellular Movement, Immune Cell Trafficking, Cell-To-Cell Signaling and Interaction |
37 |
Cellular Assembly and Organization, Cancer, Organismal Injury and Abnormalities |
33 |
Dermatological Diseases and Conditions, Developmental Disorder, Hereditary Disorder |
33 |
Cell-To-Cell Signaling and Interaction, Cell Morphology, Cellular Movement |
31 |
Organismal Development, Cardiovascular System Development and Function, Hematological System Development and Function |
20 |
P versus H |
Cell Death and Survival, Cell Signaling, Post-Translational Modification |
34 |
Dermatological Diseases and Conditions, Organismal Injury and Abnormalities, Cancer |
34 |
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities |
28 |
Cardiac Arrhythmia, Cardiovascular Disease, Organismal Injury and Abnormalities |
28 |
Cellular Compromise, Inflammatory Response, Infectious Diseases |
23 |